000163922 001__ 163922
000163922 005__ 20240229123201.0
000163922 0247_ $$2doi$$a10.14309/ctg.0000000000000243
000163922 0247_ $$2pmid$$apmid:33031193
000163922 0247_ $$2altmetric$$aaltmetric:92045964
000163922 037__ $$aDKFZ-2020-02146
000163922 041__ $$aeng
000163922 082__ $$a610
000163922 1001_ $$0P:(DE-He78)b3928caa1d0865f09ffc5cf5e7683da6$$aChen, Chen$$b0$$eFirst author
000163922 245__ $$aSelf-Reported Lower Gastrointestinal Endoscopy Use and Changes in Colorectal Cancer Mortality Rates in European Countries.
000163922 260__ $$aLondon$$bNature Publ. Group$$c2020
000163922 3367_ $$2DRIVER$$aarticle
000163922 3367_ $$2DataCite$$aOutput Types/Journal article
000163922 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1602240817_25099
000163922 3367_ $$2BibTeX$$aARTICLE
000163922 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163922 3367_ $$00$$2EndNote$$aJournal Article
000163922 500__ $$a#EA:C070#LA:C070#
000163922 520__ $$aTo quantify the association of self-reported lower gastrointestinal endoscopy use measured in 2004/05 with colorectal cancer (CRC) mortality changes over 2004-2015 in Europe.An ecological analysis was performed using endoscopy utilization data from the Survey of Health, Aging, and Retirement in 11 European countries in 2004/05 and CRC mortality data from the World Health Organization Mortality Database over 2004-2015. Mortality trends were compared through annual mortality changes from joinpoint regression models. Cross-national variations in mortality trends with respect to endoscopy use were tested for statistical significance by negative binomial regression models.The proportion of respondents who reported having had an endoscopy within 10 years varied widely across countries, from 6.1% to 25.1%. Large disparities in CRC mortality trends were also observed, with annual mortality change ranging from a decline of 3.3% to an increase of 0.9% for men and from a decline of 3.3% to a decline of 0.6% for women. Endoscopy uptake was negatively associated with the magnitude of annual mortality change over 2004-2015 (rate ratio for a 10-year mortality change per 10% higher endoscopy use, 0.88; 95% confidence interval, 0.82-0.94).This analysis provides quantitative evidence on the contributions of endoscopy use to CRC mortality declines in European countries over the past decade. A considerable fraction of protection is likely to be delivered through endoscopic removal of adenomas and sessile serrated lesions. With many European countries having recently implemented CRC screening programs, an increase in endoscopy use and a subsequent reduction in CRC mortality would be expected.
000163922 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000163922 588__ $$aDataset connected to CrossRef, PubMed,
000163922 7001_ $$0P:(DE-He78)908880209a64ea539ae8dc5fdb7e0a91$$aStock, Christian$$b1
000163922 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b2$$udkfz
000163922 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b3$$eLast author$$udkfz
000163922 773__ $$0PERI:(DE-600)2581516-7$$a10.14309/ctg.0000000000000243$$gVol. 11, no. 10, p. e00243 -$$n10$$pe00243 $$tClinical and translational gastroenterology$$v11$$x2155-384X$$y2020
000163922 909CO $$ooai:inrepo02.dkfz.de:163922$$pVDB
000163922 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b3928caa1d0865f09ffc5cf5e7683da6$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000163922 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)908880209a64ea539ae8dc5fdb7e0a91$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000163922 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000163922 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000163922 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000163922 9141_ $$y2020
000163922 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN TRANSL GASTROEN : 2018$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-01-15
000163922 915__ $$0LIC:(DE-HGF)CCBYNCNDNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)$$bDOAJ$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-15
000163922 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-01-15
000163922 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000163922 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000163922 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000163922 980__ $$ajournal
000163922 980__ $$aVDB
000163922 980__ $$aI:(DE-He78)C070-20160331
000163922 980__ $$aI:(DE-He78)C120-20160331
000163922 980__ $$aI:(DE-He78)HD01-20160331
000163922 980__ $$aUNRESTRICTED